Appendix 4D - Half-year Financial Report - 31 December 2025
Filed with ASX · · 21 pages · English
This report is based on accounts to which one of the following applies:(Tick one) If the accounts have not yet been audited or subject to review and are likely to be subject to dispute or qualification, a description of the likely dispute or qualification: The review report is an unqualified review opinion Memphasys Limited and its controlled entities # ABN 33 120 047 556 Consolidated Financial St
Earlier from Memphasys
- Memphasys Secures TGA Approval for Felix System
- Memphasys announces successful $800,000 Capital Raising
- Trading Halt
- Regulatory Submissions Lodged for Felix
- Qatar's largest IVF Institution Places MENA Orders for Felix
Later from Memphasys
- MENA Orders Secured, Expanded & Operations Unaffected
- Investor Presentation - April 2026
- Quarterly Activities/Appendix 4C Cash Flow Report
- ITL Orders 1000 Felix Cartridges Across MENA Markets
- South-East Asian Commercialization Agreement Secured
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys